A safe haven for your wealth


We are multicultural with various backgrounds (engineering, management, banking…). We think differently and challenge each other. When we suggest a solution, the subject has been duly scanned and discussed.

Board of Directors & Management

Investment Team

Support Team

Advisory Board

+30 years of experience in investments

Former Chief Investment Officer of ABN

Former Member of the Board of Directors of Neuflize Life Insurance

Lecturing in leadership and professional training at INSEAD and Cambridge Judge Business School of Management

Regular speaker at CNBC, CNN, Bloomberg TV and major networks

Didier Duret

Chairman of the Board of Directors & Head of Investment Committee

12 years in the banking world

Former Banker at Barclays/Citi Bank/UBP

ETH Zurich- MTEC Major in Finance

EPF Lausanne – BSc System of Communication

Certificate from MIT Sloan on AI

Certificate from Harvard Business School on Private Equity and VC

Hassine Benaissa

Managing Partner & Board Member

10 years in Finance

Experimented Wealth Manager

Former Private Banker at Bank UBS & Bank UBP

Damian Padua

Senior Relationship Manager and Board Member

+15 years of experience as Attorney at Law

Partner at Lenz and Staehelin

Member of the Geneva Bar Association and the Swiss Bar Association

Master in Corporate Law at New York University

Rayan Houdrouge

Board Member

+20 years of experience in Finance

Former Head of Advisory Desk at Merrill Lynch

Managing Director & Partner at Generation ALFA SA

Mirko Visco

Senior Investment Advisor & Board Member

+15 years in Finance

Head of Quant and MultiAsset Senior PM at Nomura, Taiwan

Deputy Head of Global Fixed Income at Amundi, USA

Msc in Financial and Applied Math, Supaero, France

Jérôme Barkate, CFA

Chief Investment Officer

+20 years of experience on Financial Investments

Former Senior Global Macro Quantitative Strategist at Dymon Asia and GAMA

Previously, Managing Director, Quantitative Strategist and Portfolio Manager at a start-up hedge fund in Singapore

Former economist for the French Ministry of Economy and Finance

M.A. from the doctoral program ESSEC-IAE
M.S. in Finance from Reims University
Currently finishing his Phd in Mathematical Economics at GREQAM

Joël Guglietta

Head of Global Investment Solutions

More than 30 years of experience in finance

Alternative Investments

Former Relationship and Project Manager

BNP-Paribas, Credit Suisse, BCV and AXA-Winterthur

Emmanuel Rytzell

Head of Alternative Investment & Research

25 years of experience in portfolio management

Former head of Asset Management at Sequoia

Former work at SAXO Bank, Credit Suisse, Arab Bank and Union Bank of Switzerland

Andre Keller

Senior Portfolio Manager

+20 of experience in Finance

Former Chief Risk Officer of Unigestion & Sequoia

Former Risk Management director at AXA Rosenberg

Former auditor & Finance Director

Graduated from Paris Dauphine

Mathieu Chacun

Chief Operating Officer

+15 years of experience in Finance

Managing Partner & Founder at ProFin Partners

Former Head of Private Banks Sales, Europe & Middle East at Royal Bank of Canada

Former Senior Sales Structured Products cross assets to Asia, Middle East at Commerzbank

Ex Auditor at Procter & Gamble

Myriam Deblanc

Structured Products Specialist

CEO at Pandora Advisory SA 

Former BNP Paribas Commodities Finance Manager

Natalia Belinskaia

Senior Relationship Manager & Trade Finance Advisor

Brikena Daku

Private Banking Executive

Manon Vial

Private Banking Executive

Advisor on Biotech Investments

Board member of Netris Pharma (France)

Previously worked as Principal for Vinci Capital (now Renaissance Management) which had portfolio companies in the biotech, diagnostic and medtech sectors (Addex, Anergis, Evolva, Immatics, Sensimed and Symetis).

Former financial analyst performing Equity research for the biotech and pharma industries at Helvea (now part of Baader Bank)

Doctorate of Medicine – MD and a Doctorate of Philosophy – PhD at the University of Geneva (Switzerland)

Luc Otten

Advisor on Biotech Investments